Introduction
Previous studies have demonstrated that morbidities and survival rates differ among races. [1] [2] [3] Esophageal squamous cell carcinoma (ESCC) is the most common histologic type of esophageal cancer (EC) in Asian population. Indeed, about half of all EC-related deaths were found in People's Republic of China and nearly all are due to ESCC.
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lin et al habits as Western residents. 12 A nationwide analysis of the demographic, clinicopathologic, and outcomes related to EC in the population-based Surveillance, Epidemiology, and End Results (SEER) database for the Chinese-Caucasian cohort has not been undertaken. Therefore, the purpose of this study was to compare demographic, clinicopathologic, and survival for Chinese and Caucasian EC patients residing in the US using data from the SEER program.
Patients and methods
Patients with a diagnosis of ESCC or EAC were identified using the SEER database from 1988 to 2012 using the International Classification of Disease for Oncology, Third Edition (ICD-O-3). All patients identified as Caucasian and Chinese residing in the US with a primary diagnosis of thoracic ESCC or EAC were included in the analysis. Patients with other racial subgroups and other histologic types were excluded. The permission was obtained to access research data files with the reference number 11252-Nov 2014. 13 This study was approved by the Ethics Committee of the First Affiliated Hospital of Xiamen University and Sun Yat-sen University Cancer Center. Informed consent is not required for use of SEER database data, as was confirmed by these ethics committees.
The following demographic, clinicopathologic, and outcomes data were collected from the SEER program: year of study, race, sex, age, histologic type, tumor location, histologic grade, SEER stage, marital status, and treatment strategies, including cancer-directed surgery (CDS) and radiotherapy. Vital status, including cause of death and the duration of follow-up, was recorded.
The χ 2 and Fisher's exact probability tests were used to analyze the differences between qualitative data. Univariate and multivariate Cox regression analyses were generated to analyze risk factors for overall survival (OS). Multivariate analysis was performed for factors which were significantly associated with OS based on univariate analysis. Calculation of survival rates was plotted by the Kaplan-Meier method and compared using the log-rank test. All data were analyzed with a SPSS statistical software package (version 21.0; IBM Corporation, Armonk, NY, USA). A value of P,0.05 was considered statistically significant.
Results
A total of 36,227 EC patients were identified. Among these patients, the majority (98.7% [35,748/36,227]) were Caucasian, and 1.3% (479/36,227) were Chinese. The demographics, clinical characteristics, and outcomes of all patients are shown in Table 1 . There were significant differences in the demographics, clinical characteristics, and treatments between the Chinese and Caucasian patients. The Chinese patients had a later year of diagnosis and remained married after EC was diagnosed. Figure 1A ). In contrast, Caucasian patients with EAC had a significantly better OS compared to Chinese patients (P=0.004; Figure 1B) .
The results of the univariate analysis on OS are shown in Table 3 . The OS was not significantly different between Chinese and Caucasian patients (P=0.767). Chinese race was associated with a better OS in patients with ESCC (P=0.001). Caucasian race was associated with a better OS in patients with EAC (P=0.006) ( Table S1 ).
The multivariate Cox proportional hazards regression model was adjusted for year of study, age, sex, tumor location, histologic grade, SEER stage, marital status, surgical treatment, and radiotherapy ( 
6437
characteristics of chinese and caucasian ec multivariate (P,0.001) analyses (Figure 2A) . In Caucasian population, EAC patients had a better OS than ESCC patients based on univariate analysis (P,0.001; Figure 2B ), but not in multivariate analysis (P=0.996).
Discussion
In the Chinese population, ESCC was the dominant type of EC, 4 whereas a majority of the American population were EAC, especially for Caucasians from the US. 5, 6 Currently, comparative studies analyzing the morbidity and prognosis between the Chinese and Caucasians populations have been rarely reported. In this study, the SEER database was used for a comparative analysis. It was found that the Chinese and Caucasians patients with EC have different clinical features and outcomes. Nevertheless, ethnicity exerts no effect upon the survival of all EC patients. Interestingly, subgroup analysis demonstrated that survival difference exists among different populations with diverse histologic OncoTargets and Therapy 2016:9
Dovepress
6439
characteristics of chinese and caucasian ec types of EC. In addition, the survival rate of Chinese ESCC patients was higher compared with Caucasians; however, the same phenomenon was not demonstrated with respect to EAC. Based on the analysis, tumor location and histologic type were the major differences between the Chinese and Caucasian races. Caucasian patients were mainly diagnosed with lower thoracic EC and EAC, whereas middle and upper thoracic EC and ESCC were mainly observed in the Chinese population, which is consistent with most previous findings. [14] [15] [16] In the Western countries, Barrett's esophagus is the primary risk factor for EAC. 17 Nevertheless, among 5,041 EC patients from a high-risk EC region in People's Republic of China, 217 patients (4.3%) were diagnosed with EAC, and only 4.6% (10/217) of these patients had Barrett's esophagus. 18 In another epidemiologic study conducted in People's Republic of China, only 1.5% of 4,422 EC patients were diagnosed with EAC. 19 The current study showed that the prevalence of EAC was 18.2% in Chinese immigrants, which was significantly higher compared with the Chinese counterparts who reside in People's Republic of China. In addition, the incidence of EAC in Chinese patients with EC tended to gradually ascend between 1988 and 2012 (P=0.054). Moreover, the location of EAC was similar to the US counterparts, predominantly involving the lower thoracic EC. This phenomenon probably results from the fact that the Chinese immigrants become more accustomed to the life and dietary habits of local residents in the US.
It was also demonstrated that the age of onset of ESCC and EAC significantly differed in the Caucasian population; however, the histologic type of EC was not correlated with the age of onset (P=0.806). Due to the lack of data with regard to migration time in the SEER database, it was difficult to evaluate the difference in EC morbidity in the Chinese race based upon the duration of dietary alteration. Esophagectomy remains the primary therapeutic strategy for EC. In this study, the survival rate of patients undergoing CDS was higher than their counterparts who did not. SEER data revealed that the localized and regional staging was observed in 65.1% of the Chinese population and 63.8% of their Caucasian counterparts. The probability of the Chinese race undergoing CDS was 23.2%, which was slightly lower compared with 31.4% in the Caucasian population;
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characteristics of chinese and caucasian ec this difference was likely related to the higher surgical difficulty in patients with upper-thoracic EC compared with lower-thoracic EC.
Previous studies have reported that ESCC patients are less likely to present with lymph node metastasis and distant recurrence. 20, 21 In this study, only 89 Chinese, but 8,728 Caucasian patients underwent lymph node dissection. Consequently, it is unreasonable to explicitly compare lymph node metastases between the two populations. The incidence of newly diagnosed distant metastasis was 35% in the Chinese and 36.2% in the Caucasian population, with no statistical significance.
In addition, the results of this study showed that the Chinese subgroup with ESCC had a significantly better OS when compared to their Caucasian counterparts, whereas no significant difference in the survival rate was observed between the Chinese and Caucasian patients with EAC. It has been demonstrated that the survival rate of Asian population with endometrial carcinoma, rectal cancer, liver cancer, and non-small-cell lung cancer was higher compared with the non-Hispanic white population. [22] [23] [24] [25] In this study, the survival rate of ESCC patients was higher compared to that of EAC patients in the Chinese population, whereas the survival rate of ESCC and EAC patients did not significantly differ in their Caucasian counterparts. The discrepancy in survival rate among different populations with diverse histologic types probably reflects the following observations. First, there are different risk factors which can induce ESCC and EAC. 9, 10 Second, a genetic difference in EC exists between the Chinese and Caucasian populations. [26] [27] [28] [29] [30] [31] [32] [33] Consequently, a genetic difference might be used to evaluate the clinical prognosis and therapeutic strategy for EC in subsequent investigations.
This study acknowledges several limitations. First, this was a retrospective study. Second, a lack of data in SEER, including chemotherapeutic regimen and dose, local and distant recurrence data, and comorbidities, limited the ability to determine the true etiology in these two races. A strength of this study was that this is the largest study evaluating EC outcomes in Chinese compared to Caucasians residing in the US. Although retrospective reviews should not carry the power of prospective studies, no prospective assessment of the outcome of Chinese and Caucasians in EC exists.
Conclusion
This study demonstrated that the presenting demographic features, tumor characteristics, and outcomes of EC patients differ between Chinese and Caucasians residing in the US. Chinese patients diagnosed with EAC tend to share clinical features which are similar to their Caucasian counterparts. Chinese patients with ESCC had a better OS than Caucasians. Further studies should be conducted to confirm these conclusions. 
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